1
Clinical Trials associated with [68Ga] B7H3 Affibody-BCH / RecruitingEarly Phase 1IIT Study of B7-H3 Mediated Tumor Immune Response Using a Whole-Body Kinetic Approach in Whole-Body PET
Based on [68Ga]B7H3 Affibody-BCH, this study investigates its radioactive uptake and imaging capabilities in tumor patients, with the aim of establishing a correlation between radioactive uptake and B7-H3 receptor expression. Utilizing whole-body PET technology, the pharmacokinetic dynamics of [68Ga]B7H3 Affibody-BCH are examined to ascertain its pharmacological characteristics. Ultimately, this research establishes a framework for pharmacokinetic analysis using whole-body PET.
100 Clinical Results associated with [68Ga] B7H3 Affibody-BCH
100 Translational Medicine associated with [68Ga] B7H3 Affibody-BCH
100 Patents (Medical) associated with [68Ga] B7H3 Affibody-BCH
100 Deals associated with [68Ga] B7H3 Affibody-BCH